China passes a major threshold in life sciences IP reform
Move to implement patent linkage is the clearest sign yet that the country is embracing pharma and biotech innovation
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.